Live Breaking News & Updates on Hisun Pharma|Page 1

Stay updated with breaking news from Hisun pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global $7.18 Billion Biosimilar Monoclonal Antibodies Markets, 2015-2019, 2023F, 2025F, 2030F


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion in 2020 at a compound annual growth rate (CAGR) of -5.18%.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.18 billion in 2023 at a CAGR of 33.13%.
This report focuses on biosimilar monoclonal antibodies market which is experiencing strong growth. The report gives a guide to the biosimilar monoclonal antibodies market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the glo ....

United States , Coherus Biosciences , Hisun Pharma , Celgen Biopharma , Laura Wood , Reliance Life Sciences , Boehringer Ingelheim , Torrent Pharmaceuticals , Office Hours Call , Genor Biopharma Co , Drug Administration , E St Office Hours Call , Intas Pharmaceuticals , Reddys Laboratories Ltd , Aurobindo Pharma , European Medicines Agency , Monoclonal Antibodies Global Market Report , Bioxpress Therapeutics , Aurobindo Pharma Limited , Topics Covered , Monoclonal Antibodies Market Characteristics , Monoclonal Antibodies Market Size And Growth , Biosimilar Monoclonal Antibodies Historic Market , The Market , Biosimilar Monoclonal Antibodies Forecast Market , Monoclonal Antibodies Market Segmentation ,